X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with AJANTA PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs AJANTA PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB AJANTA PHARMA UNICHEM LAB/
AJANTA PHARMA
 
P/E (TTM) x 22.0 20.0 110.2% View Chart
P/BV x 2.3 8.6 26.8% View Chart
Dividend Yield % 0.8 0.7 118.0%  

Financials

 UNICHEM LAB   AJANTA PHARMA
EQUITY SHARE DATA
    UNICHEM LAB
Mar-16
AJANTA PHARMA
Mar-16
UNICHEM LAB/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs3341,720 19.4%   
Low Rs1741,103 15.8%   
Sales per share (Unadj.) Rs146.9194.6 75.5%  
Earnings per share (Unadj.) Rs11.945.2 26.3%  
Cash flow per share (Unadj.) Rs16.250.3 32.2%  
Dividends per share (Unadj.) Rs2.008.00 25.0%  
Dividend yield (eoy) %0.80.6 138.9%  
Book value per share (Unadj.) Rs105.1132.0 79.6%  
Shares outstanding (eoy) m90.8488.77 102.3%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x1.77.3 23.8%   
Avg P/E ratio x21.431.2 68.4%  
P/CF ratio (eoy) x15.728.1 55.9%  
Price / Book Value ratio x2.410.7 22.6%  
Dividend payout %16.817.7 95.1%   
Avg Mkt Cap Rs m23,073125,299 18.4%   
No. of employees `0005.7NA-   
Total wages/salary Rs m2,5582,570 99.5%   
Avg. sales/employee Rs Th2,352.5NM-  
Avg. wages/employee Rs Th450.9NM-  
Avg. net profit/employee Rs Th190.4NM-  
INCOME DATA
Net Sales Rs m13,34617,275 77.3%  
Other income Rs m192166 115.4%   
Total revenues Rs m13,53817,442 77.6%   
Gross profit Rs m1,6395,807 28.2%  
Depreciation Rs m390451 86.6%   
Interest Rs m2949 58.9%   
Profit before tax Rs m1,4125,474 25.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m-40-   
Extraordinary Inc (Exp) Rs m-350-   
Tax Rs m2931,460 20.0%   
Profit after tax Rs m1,0804,014 26.9%  
Gross profit margin %12.333.6 36.5%  
Effective tax rate %20.726.7 77.7%   
Net profit margin %8.123.2 34.8%  
BALANCE SHEET DATA
Current assets Rs m5,9797,639 78.3%   
Current liabilities Rs m2,4322,715 89.6%   
Net working cap to sales %26.628.5 93.3%  
Current ratio x2.52.8 87.4%  
Inventory Days Days6343 145.9%  
Debtors Days Days6079 76.7%  
Net fixed assets Rs m6,4036,914 92.6%   
Share capital Rs m182177 102.7%   
"Free" reserves Rs m9,29311,442 81.2%   
Net worth Rs m9,54811,721 81.5%   
Long term debt Rs m230149 154.9%   
Total assets Rs m12,84314,814 86.7%  
Interest coverage x50.0112.9 44.3%   
Debt to equity ratio x00 190.2%  
Sales to assets ratio x1.01.2 89.1%   
Return on assets %8.627.4 31.5%  
Return on equity %11.334.2 33.0%  
Return on capital %14.346.5 30.8%  
Exports to sales %29.255.1 53.0%   
Imports to sales %6.36.0 105.6%   
Exports (fob) Rs m3,9009,527 40.9%   
Imports (cif) Rs m8471,038 81.6%   
Fx inflow Rs m4,35610,422 41.8%   
Fx outflow Rs m1,1621,678 69.3%   
Net fx Rs m3,1948,744 36.5%   
CASH FLOW
From Operations Rs m1,1193,264 34.3%  
From Investments Rs m-853-2,093 40.8%  
From Financial Activity Rs m-334-1,186 28.2%  
Net Cashflow Rs m-68-15 461.5%  

Share Holding

Indian Promoters % 50.1 73.8 67.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 1.6 974.2%  
FIIs % 3.0 7.6 39.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 17.0 186.5%  
Shareholders   20,176 20,968 96.2%  
Pledged promoter(s) holding % 0.0 4.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   ASTRAZENECA PHARMA  ALEMBIC PHARMA  CADILA HEALTHCARE  GSK PHARMA  PANACEA BIOTECH  

Compare UNICHEM LAB With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Recovery of Global Markets, Apex Frozen Food IPO & Cues to Watch Out Today(Pre-Open)

Indian stock markets remained range-bound in lacklustre trade on Tuesday as market participants kept to the sidelines in the absence of clear triggers.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Aug 22, 2017 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 8-QTR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS